Group One Trading
ZYME icon

Group One Trading’s Zymeworks ZYME Stock Holding History

Group One Trading’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$5.27K – 8940
2025
Q4 		$5.27K Sell
200
-3,300
-94% -$72K ﹤0.01% 7159
2025
Q3 		$59.8K Buy
3,500
+1,200
+52% +$17.2K ﹤0.01% 5796
2025
Q2 		$28.9K Buy
+2,300
New +$27.4K ﹤0.01% 6020
2024
Q4 		– Sell
-199,700
Closed -$2.51M – 8071
2024
Q3 		$2.51M Buy
+199,700
New +$2.17M 0.01% 1548
2024
Q2 		– Sell
-19,200
Closed -$202K – 7605
2024
Q1 		$202K Buy
19,200
+17,400
+967% +$193K ﹤0.01% 3554
2023
Q4 		$18.7K Sell
1,800
-21,100
-92% -$168K ﹤0.01% 5795
2023
Q3 		$145K Sell
22,900
-48,400
-68% -$357K ﹤0.01% 4089
2023
Q2 		$616K Buy
71,300
+39,700
+126% +$355K ﹤0.01% 2811
2023
Q1 		$286K Buy
31,600
+15,800
+100% +$138K ﹤0.01% 3331
2022
Q4 		$124K Buy
+15,800
New +$111K ﹤0.01% 4246
2022
Q3 		– Sell
-400
Closed -$2K – 8367
2022
Q2 		$2K Sell
400
-49,600
-99% -$300K ﹤0.01% 7453
2022
Q1 		$328K Sell
50,000
-3,100
-6% -$27.6K ﹤0.01% 4274
2021
Q4 		$870K Buy
53,100
+29,800
+128% +$621K ﹤0.01% 3500
2021
Q3 		$677K Buy
23,300
+9,900
+74% +$329K ﹤0.01% 3862
2021
Q2 		$465K Sell
13,400
-13,600
-50% -$431K ﹤0.01% 4297
2021
Q1 		$853K Sell
27,000
-49,700
-65% -$2.02M ﹤0.01% 3418
2020
Q4 		$3.63M Buy
76,700
+67,600
+743% +$3.14M 0.01% 1543
2020
Q3 		$424K Sell
9,100
-4,100
-31% -$141K ﹤0.01% 2990
2020
Q2 		$476K Sell
13,200
-8,900
-40% -$328K ﹤0.01% 2684
2020
Q1 		$784K Buy
+22,100
New +$904K 0.01% 1711
2019
Q2 		– Sell
-200
Closed -$3K – 5460
2019
Q1 		$3K Buy
200
+100
+100% +$1.55K ﹤0.01% 4540
2018
Q4 		$1K Buy
+100
New +$1.31K ﹤0.01% 4757

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Group One Trading's ZYME Position: Q1 2026 in Review

Group One Trading sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 8,841 shares — an estimated $209K sold.

Group One Trading first reported a position in ZYME in Q2 2019 and held it in 20 quarters. The position peaked at $529K in Q1 2022. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Group One Trading reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 8,841 Zymeworks shares in Q1 2026, an estimated $209K.
  • Group One Trading first reported a position in Zymeworks in Q2 2019 and held it in 20 quarters.
  • Group One Trading's Zymeworks position peaked at $529K in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.